Palliative Radiotherapy clinical trials
3 indexed studies · 1 currently recruiting
- RecruitingPHASE3
A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.
This study looks at a special type of strong radiation, called SABR, for people with a few small cancer spots that have spread, along with a main tumor. It compares SABR plus usual care to just usual care to see if it helps.
For: Metastatic TumorCanada · Switzerland - Active not recruitingNA
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer
This study looks at a new, more precise radiotherapy (SABR) for people with 1 to 3 small cancer growths that have spread. We are comparing it to standard radiotherapy to see if it helps people live longer, improves quality of life, and is good value for money.
For: Metastatic TumorsAustralia · Canada · Ireland - Active not recruitingPHASE2
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET)
This study compares a new, highly focused radiation treatment called SABR with standard radiation for people with a small number of cancers that have spread. It aims to see if SABR improves how long people live and their quality of life.
For: Metastatic TumorsAustralia · Canada · Netherlands